Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Journal of Internal Medicine|September 22, 2025
Long-term efficacy of rituximab versus intravenous cyclophosphamide for severe ANCA-associated vasculitis in multicenter REVEAL cohort studyShogo Matsuda, Takuya Kotani, Daisuke Nishioka, et al.
Modern Rheumatology|December 12, 2025
Rituximab versus intravenous cyclophosphamide for anti-neutrophil cytoplasmic antibody-associated vasculitis with severe renal impairment: a multicentre REVEAL cohort studyHirofumi Miyake, Ayana Okazaki, Shogo Matsuda, et al.
Rheumatology (Oxford, England)|October 24, 2025
Effect of treat-to-target strategies on maternal and neonatal outcomes of rheumatoid arthritis: a multicentre real-world ANSWER cohort studyYuri Hiramatsu, Takuya Kotani, Eri Nakamura, et al.
Modern Rheumatology|September 16, 2022
Prognostic factors affecting respiratory-related death in patients with rheumatoid arthritis complicated by interstitial lung disease: An ANSWER cohort studyHidehiko Makino, Takuya Kotani, Kenichiro Hata, et al.
Modern Rheumatology|July 24, 2025
Validation of the MCK model for predicting outcomes in myopathy-associated interstitial lung disease: a multicentre MYKO cohort studyHirofumi Miyake, Ran Nakashima, Hideaki Tsuji, et al.
Internal Medicine (Tokyo, Japan)|May 14, 2025
Differences in Organ Damage Based on Age at Onset in Idiopathic Inflammatory Myopathies: A Retrospective Multicenter MYKO StudyHideaki Tsuji, Yuki Aitani, Yudai Koshida, et al.
International Journal of Molecular Sciences|April 28, 2023
Prognostic Factors Affecting Death in Patients with Rheumatoid Arthritis Complicated by <i>Pneumocystis jirovecii</i> Pneumonia and One-Year Clinical Course: The ANSWER Cohort StudyHideyuki Shiba, Takuya Kotani, Koji Nagai, et al.
Rheumatology (Oxford, England)|June 24, 2023
IL-6 inhibitors and JAK inhibitors as favourable treatment options for patients with anaemia and rheumatoid arthritis: ANSWER cohort studyYoichi Nakayama, Ryu Watanabe, Wataru Yamamoto, et al.
Rheumatology (Oxford, England)|March 20, 2025
Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER CohortKohei Tsujimoto, Kosuke Ebina, Satomi Okamura, et al.
Clinical Immunology (Orlando, Fla.)|October 2, 2024
Anti-interferon gamma-inducible protein 16 antibodies: Identification of a novel autoantigen in idiopathic interstitial pneumonia and its clinical characteristics based on a multicenter cohort studyTsuneo Sasai, Ran Nakashima, Tomohiro Handa, et al.
Pageof 11